Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model

Folia Parasitologica

Volumn 50, Issue 1, 2003, Pages 19-22

  Li, Xunde ^a   Brasseur, Philippe ^a   Agnamey, Patrice ^a   Leméteil, Denis ^a   Favennec, Loïc ^a   Ballet, Jean Jacques ^b   Rossignol, Jean François ^c  

^a UNIVERSITÉ DE ROUEN   (France)

^b CHU Clemenceau   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cryptosporidium parvum; Immunosuppressed rat model; Nitazoxanide

Indexed keywords

ANIMALIA; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM;

EID: 0037368009     PISSN: 00155683     EISSN: None     Source Type: Journal    
DOI: 10.14411/fp.2003.003     Document Type: Article

References (23)

1. BICART-SEE A., MASSIP P., LINAS M.D., DATRY A. 2000: Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS. Antimicrob. Agents Chemother. 44: 167-168.
2. BLAGBURN B.L., DRAIN K.L., LAND T.M., KINARD R.G., MOORE P.H., LINDSAY D.S., PATRICK D.A., BOYKIN D.W., TIDWELL R.R. 1998: Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob. Agents Chemother. 42: 2877-2882.
3. BLAGBURN B.L., SOAVE R. 1997: Prophylaxis and chemotherapy: human and animal. In: R. Fayer (Ed.), Cryptosporidium and Cryptosporidiosis. CRC Press, Boca Raton, pp. 111-128.
4. BRASSEUR P., FAVENNEC L., LEMÉTEIL D., ROUSSEL F., BALLET J.J. 1994: An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin. Folia Parasitol. 41: 13-16.
5. BRASSEUR P., LEMÉTEIL D., BALLET J.J. 1988: Rat model for human cryptosporidiosis. J. Clin. Microbiol. 26: 1037-1039.
6. DAVIS L.J., SOAVE R., DUDLEY R.E., FESSEL J.W., FAULKNER S., MAMAKOS J.P. 2000: Nitazoxanide (NTZ) for AIDS-related cryptosporidial diarrhea (CD): an open-label safety, efficacy and pharmacokinetic study. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C., abstract LM50, p. 289.
7. DOUMBO O., ROSSIGNOL J.F., PICHARD E., TRAORE H.A., DEMBELE T.M., DIAKITE M., TRAORE F., DIALLO D.A. 1997: Nitazoxanide in treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am. J. Trop. Med. Hyg. 56: 637-639.
8. DUBREUIL L., HOUCKE I., MOUTON Y., ROSSIGNOL J.F. 1996: In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob. Agents Chemother. 40: 2260-2270.
9. GRIFFITHS J.L. 1998: Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment and diagnosis. Adv. Parasitol. 40: 37-85.
10. HEALEY M.C., YANG S., RASMUSSEN K.R., JACKSON M.K., DU C. 1995: Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. J. Parasitol. 81: 114-116.
11. HEINE J. 1982: Eine einfache Nachweismethode für Kryptosporidien im Kot. Zentralbl. Veterinaermed. 29: 324-327.
12. LEMÉTEIL D., ROUSSEL F., FAVENNEC L., BALLET J.J., BRASSEUR P. 1993: Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. J. Infect. Dis. 167: 766-768.
13. McVAY C.S., ROLFE R.D. 2000: In vitro and in vivo activities of nitazoxanide against Clostridium difficile. Antimicrob. Agents Chemother. 44: 2254-2258.
14. MÉGRAUD F., OCCHIALINI A., ROSSIGNOL J.F. 1998: Nitazoxanide, a potential drug to eradicate Helicobacter pylori with no cross resistance to metronidazole. Antimicrob. Agents Chemother. 42: 2836-2840.
15. ROSSIGNOL J.F., AYOUB A., AYERS M.S. 2001: Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J. Infect. Dis. 184: 103-106.
16. ROSSIGNOL J.F., ABAZA H., FRIEDMAN H. 1998a: Successful treatment of human fascioliasis with nitazoxanide. Trans. R. Soc. Trop. Med. Hyg. 92: 103-104.
17. ROSSIGNOL J.F., HIDALGO H., FEREGRINO M., HIGUERA F., GOMEZ W.H., ROMERO J.L., PADIERNA J., GEYNE A., AYERS M.S. 1998b: A double-blind placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans. R. Soc. Trop. Med. Hyg. 92: 663-666.
18. ROSSIGNOL J.F., MAISONNEUVE H. 1984: Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana. Am. J. Trop. Med. Hyg. 33: 511-512.
19. ROUSSEL F., FAVENNEC L., LEMÉTEIL D., TAYOT J., BALLET J.J., BRASSEUR P. 1996: Biliary tract cryptosporidiosis in an immunosuppressed rat model. Int. J. Parasitol. 26: 19-24.
20. THEODOS C.M., GRIFFITHS J.K., D'ONFRO J., FAIRFIELD A., TZIPORI S. 1998: Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother. 42: 1959-1965.
21. TZIPORI S. 1998: Cryptosporidiosis: laboratory investigation and chemotherapy. Adv. Parasitol. 40: 187-221.
22. TZIPORI S., RAND W., GRIFFITHS J., WIDMER G., CRABB J. 1994: Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin. Diagn. Lab. Immunol. I: 450-463.
23. VERDON R., POLIANSKI J., GAUDEBOUT C., MARCHE C., GARRY L., CARBON C., POCIDALO J.J. 1995: Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat model. Antimicrob. Agents Chemother. 39: 2155-2157.